Reuters logo
7 months ago
BRIEF-Celyad announces registration of first pancreatic cancer patient in its CAR-T NKR-2 THINK Trial in Belgium
January 11, 2017 / 6:09 PM / 7 months ago

BRIEF-Celyad announces registration of first pancreatic cancer patient in its CAR-T NKR-2 THINK Trial in Belgium

Jan 11 (Reuters) - Celyad Sa

* Announces registration of first pancreatic cancer patient in its CAR-T NKR-2 THINK Trial in Belgium Source text: bit.ly/2jjM82G Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below